[Clinical experience with cefoxitin in the field of internal medicine (author's transl)].
1) Cefoxitin (CFX) was administered to seven patients: two with acute pneumonia, two with acute pyelonephritis, one with pyonephrosis complicated to pyelolithotomy, one with acute cystitis and one with CONN syndrome complicated to liver cirrhosis. 2) Response to the CFX treatment was excellent in three patients, good in three, and poor in one. 3) No side effect was observed in all cases. In two patients in whom CFX and furosemide were concomitantly administered, no aggravation of the renal function was observed.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D002440:Cefoxitin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009401:Nephrosis / Q000188:drug therapy*; D011014:Pneumonia / Q000188:drug therapy*; D011704:Pyelonephritis / Q000188:drug therapy*
D002511:Cephalosporins; D002440:Cefoxitin